Rising rates and inflation have frazzled investors. The latest statements from the Federal Reserve didn’t assuage those anxieties. Read More
John Persinos is the editorial director of Investing Daily, overseeing such publications as Personal Finance, Utility Forecaster, Profit Catalyst Alert, Rapier's Income Accelerator, Income Forecaster, and Marijuana Investing Daily, among others. John also writes the Mind Over Markets daily stock market recap, and he's the chief investment strategist of Marijuana Profit Alert.
John has decades of experience in the technology and political realms. He has worked as a staff editor at Inc. and Venture magazines, and written for Kiplinger's, Street Authority, Investing Answers, and TheStreet.com, to name a few. In a career that has spanned more than 40 years, John has been diligently and prolifically covering the news and its impact on investors.
John also has experience with the inner-workings of Capitol Hill, serving as a press secretary to U.S. Rep. Byron Dorgan (D-ND). John started his career as a daily newspaperman with The Orlando Sentinel.
John holds undergraduate and graduate degrees from Boston University. He also completed the Davenport Fellowship in Business and Economics Reporting at the University of Missouri (Columbia).
Analyst Articles
Technology was in the lead on Wall Street for the past two years, but the hawkish turn in monetary policy has derailed the sector. Read More
Here’s our recurring roundup of major news and trends that affect the marijuana industry and its investors. Read More
Stocks have gotten clobbered amid rising volatility, with tech shares faring the worst. But running for the exits is a poor choice. Read More
Rising inflation, Fed tightening, the Omicron outbreak, and chronic disruptions in the jobs market and supply chain are clobbering stocks. Read More
It’s been a rough year so far for equities, but there’s justification for buying on the dips. Here’s a look at the reasons for optimism. Read More
A new study reveals that certain cannabis compounds in lab tests prevented COVID from invading healthy human cells. Read More
As rates rise, inflation worsens, and the Fed tightens, investors are nervous. Here’s what we know, and don’t know, about markets conditions. Read More
Rather than fret about the possibility of a sudden calamity, investors should be more worried right now about known problems in plain view. Read More
To position your portfolio for optimal performance, it’s important to understand the current stage of the economic expansion. Read More